Herpes simplex virus type-2 infection in pregnancy: No risk of fetal death: Results from a nested case-control study within 35,940 women

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 109, Issue 9, 2002, Pages 1030-1035

  Eskild, Anne ^a,b   Jeansson, Stig ^b   Stray Pedersen, Babill ^c   Jenum, Pål A ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; PARITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 0036753630     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(02)01934-1     Document Type: Article

References (25)

1. Whitley R., Arvin A., Prober Cet al. Predictors of morbidity and mortality in neonates with herpes simplex infections. N Engl J Med. 324:1991;450-454.
2. Brown Z.A., Benedetti J., Ashley Ret al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 324:1991;1247-1252.
3. Prober C.G., Hensleigh P.A., Boucher F.D., Yasukawa L.L., Au D.S., Arvin A.M. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus. N Engl J Med. 318:1988;887-891.
4. Kulhanjian J.A., Soroush V., Au DSet al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med. 326:1992;916-920.
5. Brown Z.A., Selke S., Zeh Jet al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 337:1997;509-515.
6. Hyde S.R., Giacoia G.P. Congenital herpes infection: placental and umbilical cord findings. Obstet Gynecol. 81:1993;852-855.
7. Mansour A.M., Nichols M.M. Congenital diffuse necrotizing retinitis. Graefe's Arch Clin Exp Ophthalmol. 231:1993;95-98.
8. Sarkell B., Blaylock W.K., Vernon H. Congenital neonatal herpes simplex virus infection. J Am Acad Dermatol. 27:1992;817-821.
9. Nahmias A.J., Josey W.E., Naib Z.M., Freeman M.G., Fernandez R.J., Wheeler J.H. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol. 110:1971;825-837.
10. Young E.J., Chafizadeh E., Oliveira V.L., Genta R.M. Disseminated herpesvirus infection during pregnancy. Clin Infect Dis. 22:1996;51-58.
11. Robb J.A., Benirschke K., Mannino F., Voland J. Intrauterine latent herpes simplex virus infection: II. Latent neonatal infection. Human Pathol. 17:1986;1210-1217.
12. Jenum P.A., Stray-Pedersen B., Melby KKet al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol. 36:1998;2900-2906.
13. . 12th Issue Statistics in Norway. Statistical Yearbook 1993. 1993;Statistics Norway, Oslo, Norway.
14. Lie R.T., Wilcox A.J., Skjærven R. A population based study of the risk of recurrence of birth defects. N Engl J Med. 331:1994;1-4.
15. Ades A.E., Peckham C.S., Dale G.E., Best J.M., Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women and estimated rates of infection. J Epidemiol Community Health. 43:1989;53-60.
16. Svennerholm B., Olofsson S., Jeansson S., Vahlne A., Lycke E. Herpes simplex type-selective enzyme-linked immunosorbent assay with Helix Pomatia lectin-purified antigens. J Clin Microbiol. 19:1984;235-239.
17. Ho D.W.T., Field P.R., Sjögren-Jansson E., Jeansson S., Cunningham A.L. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods. 36:1992;249-264.
18. Eskild A., Nesheim B-I, Berglund T., Totlandsdal J.K., Andresen J.F. Geographical variation in induced abortion after 12th pregnancy week in Norway 1996-97. J Nor Med Assoc. 121:2001;24-27. [in Norwegian].
19. Eskild A., Nesheim B-I, Berglund T., Totlandsdal J.K., Andresen J.F. Induced abortion due to fetal malformation in Norway 1996-97. J Nor Med Assoc. 120:2000;1000-1003. [in Norwegian].
20. Births in Norway through 30 years. Medical Birth Registry of Norway 1967-96. 1997;Medical Birth Registry, Bergen. [in Norwegian].
21. Christenson B., Böttiger M., Svensson Å, Jeansson S. A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls. J Infect. 25:1992;147-154.
22. Eskild A., Jeansson S., Hagen J., Jenum P.A., Skrondal A. Herpes simplex virus type-2 antibodies in pregnant women: the impact of the stage of pregnancy. Epidemiol Infect. 125:2000;685-692.
23. Yasuhara M., Tamaki H., Iyama S., Yamaguchi Y., Tachi J., Amino N. Reciprocal changes in serum levels of immunoglobulins (IgG, IgA, IgM) and complements (C3, C4) in normal pregnancy and after delivery. J Clin Lab Immunol. 38:1992;137-141.
24. Amino N., Tanizawa O., Miyai Ket al. Changes of serum immunoglobulins IgG, IgA, IgM, and IgE during pregnancy. Obstet Gynecol. 52:1978;415-420.
25. Arvaja M., Lethinen M., Koskela P., Lappalainen M., Paavonen J., Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 in pregnancy. Sex Transm Infect. 75:1999;168-171.